Shanghai City, China Clinical Trials

A listing of Shanghai City, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1288 clinical trials
A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression

The study evaluates the efficacy and safety of lurasidone compared with placebo in treating Bipolar I Depression.

Shanghai Tongji Hospital
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2021
  • +23 other locations
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of CD19 positive Relapsed or Refractory acute lymphoblastic leukemia.

Tongji Hospital of Tongji University
 (2.9 away) Contact site
  • 0 views
  • 17 Feb, 2021
  • +8 other locations
Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction

This is a prospect, multi-center, random study to investigate whether early offering PCSK9 inhibitor to acute myocardium infarction(AMI) can alleviate ventricular remodeling after primary percutaneous intervention(PPCI). Totally,twenty acute myocardium infarction subjects will be enrolled in this study after consent information. After randomization, the control group will receive standard therapy for …

Tongren Hospital, Shanghai
 (0.0 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +1 other locations
An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor

This is an exploratory clinical study of Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1) in patients with advanced malignant tumor.

Dragonboat Biopharmaceutical,Co.,Ltd
 (0.0 away) Contact site
  • 0 views
  • 16 Feb, 2021
  • 1 location
Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients

To assess the efficacy and safety of 0.5mg Fingolimod (Gilenya) in Chinese patients with relapsing relapsing multiple sclerosis (RMS)

Novartis Investigative Site
 (1.1 away) Contact site
  • 0 views
  • 20 Aug, 2021
  • +8 other locations
Carbon Nanoparticles vs Indocyanine Green

Both nano carbon and ICG as lymph node tracers in colorectal cancer have their own value, this study was to contrast two tracers in colorectal cancer surgeries, so as to find out the best lymphnode tracer in colorectal cancer, in order to further improve postoperative lymph node inspection, precise postoperative …

Fudan University Shanghai Cancer Center
 (2.3 away) Contact site
  • 0 views
  • 24 Feb, 2021
  • 1 location
Guo's Subclavian Artery Reconstruction: The Prospective Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

This study is a prospective, multiple center study to evaluate the safety and effectiveness of WeFlow-Tbranch single embedded branch thoracic aorta stent graft system manufactured by EndoNom Medtech (Hangzhou) Co., Ltd.

Shanghai Jiaotong University Affiliated Ninth People's Hospital
 (0.0 away) Contact site
  • 0 views
  • 05 Mar, 2021
  • +28 other locations
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

A prospective one-arm study of pegylated liposomal doxorubicin combined with anlotinib for neoadjuvant treatment of locally advanced soft tissue sarcoma.

Fudan University Shanghai Cancer Center
 (2.3 away) Contact site
  • 0 views
  • 02 Mar, 2021
  • 1 location
SBRT for Oligoprogressive NSCLC After Treatment With PD-1 Immune Checkpoint Inhibitors

Despite the impressive response rate to PD-1 immune checkpoint inhibitors, resistance inevitably develops in most patients. Stereotactic body radiation therapy (SBRT) plays a growing role in the management of oligometastatic disease. This study aims to evaluate the efficacy and safety of SBRT for oligoprogressive NSCLC after treatment with PD-1 inhibitors.

Fudan University Shanghai Cancer Center
 (2.3 away) Contact site
  • 0 views
  • 04 Mar, 2021
  • 1 location
Guo's Aortic Arch Reconstruction :The Prospective Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

A prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for true/false aortic arch aneurysms and ulcers involving aortic arch . (GIANT Study)

The Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
 (0.0 away) Contact site
  • 0 views
  • 01 Mar, 2021
  • +22 other locations